Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T89988 | Target Info | |||
Target Name | C-C chemokine receptor type 2 (CCR2) | ||||
Synonyms |
Monocyte chemoattractant protein 1 receptor; MCP-1-R; Chemokine receptor CCR2B; CMKBR2; CD192; CCR-2; CC-CKR-2; C-C CKR-2
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | CCR2 | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | C-C chemokine receptor type 5 (CCR5) | Successful Target | ||||
UniProt ID | CCR5_HUMAN | |||||
Gene Name | CCR5 | |||||
Synonyms |
HIV-1 fusion coreceptor; HIV-1 fusion co-receptor; Chemokine receptor CCR5; CMKBR5; CHEMR13; CD195 antigen; CD195; CCR-5; CC-CKR-5; C-C CKR-5
Click to Show/Hide
|
|||||
Representative Drug(s) | Cenicriviroc | Drug Info | IC50 = 3 nM | [1] | ||
Co-Target Name | C-C chemokine receptor type 7 (CCR7) | Literature-reported Target | ||||
UniProt ID | CCR7_HUMAN | |||||
Gene Name | CCR7 | |||||
Synonyms |
MIP3 beta receptor; MIP-3 beta receptor; EpsteinBarr virusinduced Gprotein coupled receptor 1; Epstein-Barr virus-induced G-protein coupled receptor 1; EVI1; EBVinduced Gprotein coupled receptor 1; EBV-induced G-protein coupled receptor 1; EBI1; CMKBR7; CDw197; CD197; CCR-7; CCCKR7; CC-CKR-7; CC chemokine receptor type 7; CC CKR7; C-C CKR-7; BLR2
Click to Show/Hide
|
|||||
Representative Drug(s) | Cenicriviroc | Drug Info | IC50 = 3.1 nM | [2] | ||
Co-Target Name | Diamine oxidase (AOC1) | Literature-reported Target | ||||
UniProt ID | AOC1_HUMAN | |||||
Gene Name | AOC1 | |||||
Synonyms |
Kidney amine oxidase; KAO; Histaminase; Amiloride-binding protein; AOC1; ABP
Click to Show/Hide
|
|||||
Representative Drug(s) | Aminoguanidine | Drug Info | Ki = 140 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Chemokine receptor antagonists. J Med Chem. 2012 Nov 26;55(22):9363-92. | ||||
REF 2 | The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. J Med Chem. 2020 May 28;63(10):5031-5073. | ||||
REF 3 | Synthesis of 4(5)-imidazolyl allylamines and propargylamines as inhibitors of diamine oxidase. Bioorg Med Chem Lett. 1993 Feb;3(2):353-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.